Róger Calderón

2.5k total citations
74 papers, 1.2k citations indexed

About

Róger Calderón is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Róger Calderón has authored 74 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Infectious Diseases, 53 papers in Epidemiology and 23 papers in Surgery. Recurrent topics in Róger Calderón's work include Tuberculosis Research and Epidemiology (61 papers), Mycobacterium research and diagnosis (27 papers) and Pneumocystis jirovecii pneumonia detection and treatment (15 papers). Róger Calderón is often cited by papers focused on Tuberculosis Research and Epidemiology (61 papers), Mycobacterium research and diagnosis (27 papers) and Pneumocystis jirovecii pneumonia detection and treatment (15 papers). Róger Calderón collaborates with scholars based in United States, Peru and Brazil. Róger Calderón's co-authors include Leonid Lecca, Megan Murray, Carmen Contreras, Jerome T. Galea, Rosa Yataco, Zibiao Zhang, Mercedes C. Becerra, Chuan-Chin Huang, Molly F. Franke and Judith Jiménez and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Róger Calderón

67 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Róger Calderón United States 21 861 704 296 181 125 74 1.2k
Erik Sturegård Sweden 21 728 0.8× 710 1.0× 467 1.6× 177 1.0× 160 1.3× 51 1.2k
Nyanda Elias Ntinginya Tanzania 16 754 0.9× 576 0.8× 226 0.8× 157 0.9× 67 0.5× 79 1.1k
Norbert Heinrich Germany 23 1.3k 1.6× 889 1.3× 457 1.5× 179 1.0× 94 0.8× 63 1.6k
Mamoudou Maïga United States 21 758 0.9× 609 0.9× 203 0.7× 372 2.1× 95 0.8× 78 1.2k
Ruwen Jou Taiwan 19 893 1.0× 783 1.1× 354 1.2× 211 1.2× 56 0.4× 71 1.2k
Henry C. Mwandumba United Kingdom 19 738 0.9× 615 0.9× 143 0.5× 227 1.3× 272 2.2× 77 1.3k
Emanuele Pontali Italy 25 1.1k 1.3× 744 1.1× 237 0.8× 193 1.1× 154 1.2× 81 1.6k
Boubacar Bah United Kingdom 14 996 1.2× 735 1.0× 372 1.3× 143 0.8× 397 3.2× 26 1.4k
Solange Alves Vinhas Brazil 17 727 0.8× 682 1.0× 280 0.9× 112 0.6× 91 0.7× 37 990
Ravesh Singh South Africa 19 414 0.5× 321 0.5× 270 0.9× 157 0.9× 195 1.6× 64 1.2k

Countries citing papers authored by Róger Calderón

Since Specialization
Citations

This map shows the geographic impact of Róger Calderón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Róger Calderón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Róger Calderón more than expected).

Fields of papers citing papers by Róger Calderón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Róger Calderón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Róger Calderón. The network helps show where Róger Calderón may publish in the future.

Co-authorship network of co-authors of Róger Calderón

This figure shows the co-authorship network connecting the top 25 collaborators of Róger Calderón. A scholar is included among the top collaborators of Róger Calderón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Róger Calderón. Róger Calderón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Platt, Georgina, Charles A. Peloquin, Julia Coit, et al.. (2025). Impact of Pharmacogenetics on Pharmacokinetics of First-Line Antituberculosis Drugs in the HIRIF Trial. The Journal of Infectious Diseases. 232(2). e258–e265.
2.
Luo, Yang, Nicole C. Howard, Xin Wang, et al.. (2024). Paired analysis of host and pathogen genomes identifies determinants of human tuberculosis. Nature Communications. 15(1). 10393–10393. 5 indexed citations
3.
Brooks, Meredith B., Brittney van de Water, Leonid Lecca, et al.. (2024). Tuberculosis treatment loss to follow-up in children exposed at home: A prospective cohort study. Journal of Global Health. 14. 4194–4194. 1 indexed citations
4.
Trevisi, Letizia, Meredith B. Brooks, Mercedes C. Becerra, et al.. (2024). Who Transmits Tuberculosis to Whom: A Cross-Sectional Analysis of a Cohort Study in Lima, Peru. American Journal of Respiratory and Critical Care Medicine. 210(2). 222–233. 2 indexed citations
5.
Yuen, Courtney M., Chuan-Chin Huang, Róger Calderón, et al.. (2023). Utility of Mycobacterium tuberculosis Genome Sequencing Snapshots to Assess Transmission Dynamics Over Time. The Journal of Infectious Diseases. 229(5). 1493–1497. 1 indexed citations
6.
Law, Stephanie, Marco Tovar, Molly F. Franke, et al.. (2023). Low detection rate of RT-PCR-confirmed COVID-19 using IgM/IgG rapid antibody tests in a large community sample in Lima, Peru. BMC Infectious Diseases. 23(1). 62–62. 1 indexed citations
7.
Calderón, Róger, María B. Arriaga, Beatriz Barreto‐Duarte, et al.. (2022). Persistent dysglycemia is associated with unfavorable treatment outcomes in patients with pulmonary tuberculosis from Peru. International Journal of Infectious Diseases. 116. 293–301. 11 indexed citations
8.
Suliman, Sara, Lars Kjer‐Nielsen, Liyen Loh, et al.. (2022). Dual TCR-α Expression on Mucosal-Associated Invariant T Cells as a Potential Confounder of TCR Interpretation. The Journal of Immunology. 208(6). 1389–1395. 6 indexed citations
9.
Huang, Chuan-Chin, Qi Tan, Mercedes C. Becerra, et al.. (2022). The Contribution of Chest Radiography to the Clinical Management of Children Exposed to Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 206(7). 892–900. 6 indexed citations
10.
Tovar, Marco, Jesús Peinado, Judith Jiménez, et al.. (2022). Integrated screening and testing for TB and COVID-19 in Peru. Public Health Action. 12(1). 7–9. 6 indexed citations
11.
Nathan, Aparna, Jessica I. Beynor, Yuriy Baglaenko, et al.. (2021). Multimodally profiling memory T cells from a tuberculosis cohort identifies cell state associations with demographics, environment and disease. Nature Immunology. 22(6). 781–793. 56 indexed citations
12.
Huang, Chuan-Chin, Mercedes C. Becerra, Róger Calderón, et al.. (2020). Isoniazid Preventive Therapy in Contacts of Multidrug-Resistant Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 202(8). 1159–1168. 16 indexed citations
13.
Mesman, Annelies W., Róger Calderón, Nira R. Pollock, et al.. (2020). Molecular detection of Mycobacterium tuberculosis from buccal swabs among adult in Peru. Scientific Reports. 10(1). 22231–22231. 14 indexed citations
14.
Reinink, Peter, Adam Shahine, Stéphanie Gras, et al.. (2019). A TCR β-Chain Motif Biases toward Recognition of Human CD1 Proteins. The Journal of Immunology. 203(12). 3395–3406. 11 indexed citations
15.
Farhat, Maha, Luca Freschi, Róger Calderón, et al.. (2019). GWAS for quantitative resistance phenotypes in Mycobacterium tuberculosis reveals resistance genes and regulatory regions. Nature Communications. 10(1). 2128–2128. 105 indexed citations
16.
Dixit, Avika, Luca Freschi, Roger Vargas, et al.. (2019). Whole genome sequencing identifies bacterial factors affecting transmission of multidrug-resistant tuberculosis in a high-prevalence setting. Scientific Reports. 9(1). 5602–5602. 21 indexed citations
17.
Velásquez, Gustavo E., Meredith B. Brooks, Julia Coit, et al.. (2018). Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial. American Journal of Respiratory and Critical Care Medicine. 198(5). 657–666. 74 indexed citations
18.
Aibana, Omowunmi, Molly F. Franke, Chuan-Chin Huang, et al.. (2017). Impact of Vitamin A and Carotenoids on the Risk of Tuberculosis Progression. Clinical Infectious Diseases. 65(6). 900–909. 72 indexed citations
19.
Zelner, Jon, Megan Murray, Mercedes C. Becerra, et al.. (2014). Bacillus Calmette-Guérin and Isoniazid Preventive Therapy Protect Contacts of Patients with Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 189(7). 853–859. 27 indexed citations
20.
Galea, Jerome T., Carmen Contreras, Leonid Lecca, et al.. (2013). Rapid home-based human immunodeficiency virus testing to reduce costs in a large tuberculosis cohort study [Short communication]. Public Health Action. 3(2). 172–174. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erik Sturegård Breakdown of academic impact, for papers by Nyanda Elias Ntinginya Breakdown of academic impact, for papers by Norbert Heinrich Breakdown of academic impact, for papers by Mamoudou Maïga Breakdown of academic impact, for papers by Ruwen Jou Breakdown of academic impact, for papers by Henry C. Mwandumba Breakdown of academic impact, for papers by Emanuele Pontali Breakdown of academic impact, for papers by Boubacar Bah Breakdown of academic impact, for papers by Solange Alves Vinhas Breakdown of academic impact, for papers by Ravesh Singh
Rankless by CCL
2026